• MS Drug Ocrelizumab Approved in Europe

    6 monthes ago - By Medscape

    The European Commission clears the anti-CD20 monoclonal antibody for adults with relapsing multiple sclerosis and early primary progressive multiple sclerosis.
    International Approvals
    Read more ...